Lyophilized peptides produced in ISO9001/GMP-aligned synthesis laboratories, rigorously inspected with triple verification: HPLC, MS, and Endotoxin screening.
South Korea stands at the forefront of East Asia's biopharmaceutical resurgence. From the Incheon Free Economic Zone (IFEZ Songdo) to the Osong Bio Valley, the national mandate for biotherapeutics, regenerative cosmeceuticals, and advanced metabolic drug models requires an agile, dependable peptide pipeline.
South Korea's top Contract Research Organizations (CROs) and biotechnology consortia rely on rapid cycle iterations. Our raw materials serve upstream metabolic research, supporting translational studies across regional bioclusters with zero synthesis delay.
Korea is the international benchmark for bio-active dermocosmetics. We supply high-grade cosmetic sequence fragments—including GHK-Cu, Matrixyl, and neuro-attenuating oligopeptides—fully matching strict MFDS safety limits for heavy metals and residual solvents.
The explosive demand for GLP-1, GIP, and glucagon multi-agonists in Korea has necessitated verifiable supply chains. Our facilities manufacture pure, sequence-certified reference peptides, eliminating cross-contamination and sub-potent batches.
Navigating global supply bottlenecks requires a manufacturing partner with vertical integration. Operating comprehensive chemical synthesis facilities in China, we manage every step from protected amino acid precursors (Fmoc/tBu chemistry) to high-throughput multi-column preparative HPLC.
Peptide fragile tertiary structures are highly sensitive to thermal variations. Our East Asia direct routes ensure continuous temperature data logging from synthesis to lab door.
The global peptide therapeutic sector is expanding at a projected CAGR exceeding 11.2%, moving past simple short oligomers toward engineered macrocyclic complexes, oral-permeable lipidated chains, and long-acting depot constructs.
Pioneering the shift toward LPPS (Liquid-Phase Peptide Synthesis) and hybrid chemo-enzymatic coupling, significantly minimizing solvent waste while enhancing the scalability of 30+ mer complex amino sequences.
Collaborating on advanced carrier matrices, SNAC-enabled formulations, and cyclic backbone stabilization to bypass gastric enzymatic degradation, addressing the highest barrier in patient-friendly peptide delivery.
Empowering Korea's targeted oncological research via Peptide-Drug Conjugates (PDC). Offering specialized cleavable/non-cleavable linker chemistry, radiolabeling chelators (DOTA, NOTA), and site-specific payload anchoring.
Procuring raw peptides internationally requires strict regulatory alignment. We provide enterprise documentation ready for immediate regulatory filing in South Korea.
Full notification and hazardous substance evaluation compliant with the Ministry of Environment (MoE).
Conforms to testing standards established by the Ministry of Food and Drug Safety for analytical raw reagents.
Analytical high-performance liquid chromatography using verified reverse-phase C18 column parameters.
Full batch genealogy tracking from raw starting materials to the final lyophilized glass vial seal.
Everything you need to know about lead times, custom peptide synthesis, analytical validation, and regional customs clearance into South Korea.
We deploy validated insulated packaging systems loaded with Phase Change Materials (PCM) or dry ice that maintain stable temperatures (< -20°C) for up to 96 hours. Shipments to Incheon, Busan, or Daegu typically clear customs and reach our clients' facilities within 48 to 72 hours, backed by continuous multi-point digital USB temperature data loggers included inside each cargo box.
Every commercial or research order is shipped with an authentic, lot-specific Certificate of Analysis (COA). This document provides exact Reverse-Phase HPLC chromatograms showing purity percentage (>98% or >99%), Electrospray Ionization Mass Spectrometry (ESI-MS) confirming molecular weight matching theoretical values, net peptide content calculation, and residual moisture/acetate testing data.
Yes. We offer comprehensive custom peptide synthesis extending from milligram-scale research batches up to multi-kilogram pilot production. Options include isotopic labeling (13C, 15N), peptide cyclization (disulfide bridge formation), N-terminal fatty acid modifications (palmitoylation for long-acting agonists), PEGylation, fluorescent tagging (FITC, FAM), and custom vial lyophilization.
We provide full commercial export declarations including proper Harmonized System (HS) code assignment, detailed commercial invoices, complete packing lists, and GHS-compliant Safety Data Sheets (SDS) in English and Korean. Materials strictly supplied for laboratory research and developmental use are properly flagged to expedite clearance through Korea Customs Service (KCS).
Explore our wholesale-ready peptide series. Every product link provides direct access to chemical specifications, batch records, and bulk volume ordering.
Connect with our senior technical procurement specialists. We provide verified HPLC/MS reports, competitive CDMO contracts, and localized shipping strategies for Korean biotech enterprises.
Send Inquiry Now
